Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04775745
Title Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Newave Pharmaceutical Inc
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Duke Univerisity RECRUITING Durham North Carolina 27708 United States Details
University of Cincinnati RECRUITING Cincinnati Ohio 45221 United States Details
Ohio State University RECRUITING Columbus Ohio 43210 United States Details
Huntsman Cancer Institute, University of Utah RECRUITING Salt Lake City Utah 84112 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field